FDA Inspection 1013811 — Alamance Regional Medical Center Blood Bank
The FDA completed an inspection of Alamance Regional Medical Center Blood Bank on June 8, 2017 in Burlington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 8, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Burlington, NC (United States)